First Financial Bank - Trust Division’s iShares US Pharmaceuticals ETF IHE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-5,069
Closed -$439K 209
2026
Q1
$439K Sell
5,069
-1,327
-21% -$116K 0.04% 152
2025
Q4
$543K Hold
6,396
0.04% 138
2025
Q3
$464K Hold
6,396
0.04% 148
2025
Q2
$419K Hold
6,396
0.04% 161
2025
Q1
$451K Hold
6,396
0.04% 150
2024
Q4
$420K Hold
6,396
0.04% 160
2024
Q3
$452K Hold
6,396
0.04% 160
2024
Q2
$424K Hold
6,396
0.04% 158
2024
Q1
$434K Sell
6,396
-17,241
-73% -$1.14M 0.04% 154
2023
Q4
$1.46M Buy
+23,637
New +$1.39M 0.15% 88

Other funds holding IHE

First Financial Bank - Trust Division's IHE Position: Q2 2026 in Review

First Financial Bank - Trust Division sold out of iShares US Pharmaceuticals ETF (IHE) in Q2 2026, closing a stake of 5,069 shares — an estimated $439K sold.

First Financial Bank - Trust Division first reported a position in IHE in Q4 2023 and held it in 10 quarters. The position peaked at $1.46M in Q4 2023. 21 funds tracked by Wall St. Rank hold IHE as of Q2 2026.

  • First Financial Bank - Trust Division reported no remaining iShares US Pharmaceuticals ETF position as of Q2 2026 after selling out during the quarter.
  • First Financial Bank - Trust Division sold 5,069 iShares US Pharmaceuticals ETF shares in Q2 2026, an estimated $439K.
  • First Financial Bank - Trust Division first reported a position in iShares US Pharmaceuticals ETF in Q4 2023 and held it in 10 quarters.
  • First Financial Bank - Trust Division's iShares US Pharmaceuticals ETF position peaked at $1.46M in Q4 2023.
  • 21 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.

Based on First Financial Bank - Trust Division's 13F filing for Q2 2026, filed 1 Jul 2026.